Laurel Wealth Advisors (California)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-15,900
Closed -$17K 425
2019
Q1
$17K Buy
+15,900
New +$17K ﹤0.01% 389